The regulation and function of CD20: an “enigma” of B-cell biology and targeted therapy

The introduction of anti-CD20 monoclonal antibodies such as rituximab, ofatumumab, or obinutuzumab improved the therapy of B-cell malignancies even though the precise physiological role and regulation of CD20 remains unclear. Furthermore, CD20 expression is highly variable between different B-cell m...

Full description

Saved in:
Bibliographic Details
Published inHaematologica (Roma) Vol. 105; no. 6; pp. 1494 - 1506
Main Authors Pavlasova, Gabriela, Mraz, Marek
Format Journal Article
LanguageEnglish
Published Italy Ferrata Storti Foundation 01.06.2020
Subjects
Online AccessGet full text

Cover

Loading…